Lipid-Polysaccharide Conjugation

Explore Lipid–Polysaccharide Conjugates from BOC Sciences

BOC Sciences has a leading platform for lipid chemistry and bioconjugation, offering precise lipid labeling and conjugation services for a variety of natural and modified polysaccharides. Supported polysaccharides include hyaluronic acid (HA), chitosan, dextran, arabinogalactan, alginate, β-glucan, starch, and their derivatives. By controlling lipid chain length, linking groups, and degree of substitution, we can customize lipid–polysaccharide conjugates for diverse applications, ensuring optimal balance of physicochemical properties and biological functionality.

Fatty Acid–Polysaccharide Conjugates

• Covalent conjugation with saturated and unsaturated fatty acids such as palmitic acid, oleic acid, and stearic acid;
• Adjustable hydrophobicity to enhance membrane affinity and emulsification capability;
• Suitable for constructing nanocarriers, controlled-release drug systems, and biocolloidal materials.

Phospholipid–Polysaccharide Conjugates

• Modification with phosphatidylcholine (PC), phosphatidylethanolamine (PE), and other phospholipids;
• Efficient conjugation via active esters, maleimides, or click chemistry;
• Applied in liposome stabilization, vaccine adjuvants, and biomimetic membrane systems.

Cholesterol–Polysaccharide Conjugates

• Formed through hydroxyl or carboxyl activation to create stable ester or ether linkages;
• Enhances polysaccharide–cell membrane interactions and cellular uptake;
• Commonly used for liposome modification, nucleic acid carriers, and cell-penetrating materials.

Glyceride–Polysaccharide Conjugates

• Incorporates mono-, di-, or tri-glyceride structures;
• Supports modulation of biocompatibility and degradability for various applications;
• Used in food emulsions, biodegradable coatings, and drug carriers.

Sphingolipid–Polysaccharide Conjugates

• Covalent conjugation with natural sphingosine or synthetic sphingolipid molecules;
• Reconstructs membrane-like microenvironments for cell signaling and receptor studies;
• Suitable for immunological research, neural membrane models, and biomimetic membrane fabrication.

PEGylated Lipid–Polysaccharide Conjugates

• Introduction of polyethylene glycol (PEG 500–5000 Da) to enhance solubility;
• Supports dual-end modification to form polysaccharide–lipid–PEG ternary structures;
• Applied in long-circulation drug carriers, lipid nanoparticle (LNP) systems, and biocompatible materials.

Cationic Lipid–Polysaccharide Conjugates

• Modification with cationic amine or quaternary ammonium groups to enhance electrostatic interactions;
• Supports complexation with DNA, mRNA, siRNA, and other nucleic acids;
• Suitable for gene delivery, vaccine delivery, and mRNA platform development.

Functionalized Lipid–Polysaccharide Conjugates

• Introduction of specific chemical groups (carboxyl, thiol, fluorophores, targeting ligands);
• Supports subsequent conjugation, labeling, or bioassay applications;
• Ideal for targeted drug delivery, imaging probes, and functional surface modifications.

Your Partner in Lipid–Polysaccharide Conjugation Solutions

BOC Sciences offers a powerful lipid chemistry and bioconjugation platform, providing end-to-end lipid–polysaccharide conjugation solutions from project design and custom synthesis to quality verification. We combine advanced lipid modification technologies with polysaccharide molecular engineering to deliver high-performance conjugates for drug delivery systems, biomaterials, vaccine adjuvants, and biosensing applications.

Custom Conjugate Design

• Develops optimal lipid–polysaccharide matching strategies based on client goals such as solubility, stability, membrane affinity, or delivery efficiency;
• Selects appropriate lipid types according to polysaccharide type (HA, chitosan, dextran, alginate, etc.);
• Supports diverse linking modes including ester, amide, ether, and click chemistry;
• Offers molecular modeling and structural visualization to predict conjugation outcomes and biological behavior.

Controlled Conjugation Chemistry & Process Development

• Establishes controlled reaction systems to precisely regulate lipid number, position, and substitution degree;
• Supports multiple conjugation strategies including active esters, NHS, EDC, and DCC;
• Combines solution-phase and solid-phase synthesis to optimize reaction efficiency and molecular integrity;
• Performs reaction condition optimization and pilot-scale studies to ensure high purity and reproducibility.

Polysaccharide Modification & Activation Services

• Provides polysaccharide molecular weight control, carboxyl/amino modification, and reducing-end activation;
• Enables chemical derivatization (e.g., thiol or alkyne introduction) for selective conjugation sites;
• Offers targeted conjugation strategies for highly branched or complex polysaccharides;
• Ensures maintenance of polysaccharide bioactivity and compliance with pharmaceutical or biocompatibility standards.

Lipid Structure Optimization

• Offers a wide range of lipid groups: fatty acids, phospholipids, cholesterols, sphingolipids, PEG lipids, etc.;
• Controls hydrophobic chain length, saturation, and functional groups;
• Optimizes lipid structures according to application (drug delivery, surface modification, emulsions);
• Provides structure–performance analysis and verification for polymeric systems.

Leading Technical and Service Advantages at BOC Sciences

• Advanced Synthesis and Analytical Capabilities: Leveraging state-of-the-art lipid chemistry and polysaccharide modification platforms, combined with HPLC, LC-MS, NMR, and other precision analysis, to achieve highly pure and structurally accurate conjugates.
• Customized Solutions: Design of lipid types and conjugation strategies tailored for different polysaccharides (HA, chitosan, glucans, etc.) to optimize hydrophobicity, delivery efficiency, and biocompatibility.
• Full-Process Quality Control: Strict adherence to GMP operations from raw material selection and reaction control to final product testing, ensuring batch consistency and traceability.
• Scalable Production Capability: Supports scale-up from milligrams to kilograms for R&D, pilot, and commercial stages with high consistency.
• Expert Scientific Team: Composed of lipid chemistry, biomaterials, and drug delivery specialists, providing end-to-end technical support from molecular design and reaction optimization to performance validation.
• Global Delivery and Continuous Support: Comprehensive international supply and project tracking systems enable efficient global delivery and long-term technical consultation.
• Advanced Facilities and Process Platforms: Equipped with high-standard organic synthesis labs, bioreaction systems, and automated purification equipment for efficient polysaccharide activation, lipid modification, and complex conjugation reactions.
• Client-Oriented Project Support: Dedicated project management ensures frequent communication on design, progress, and results, guaranteeing timely and high-quality project completion.

Streamlined Lipid–Polysaccharide Conjugation Service Workflow

The lipid–polysaccharide conjugation workflow at BOC Sciences is systematically designed and strictly quality-controlled to ensure that every step, from project initiation to delivery, is efficient, traceable, and reproducible, meeting the multi-level demands of both R&D and industrial applications.

Requirement Analysis & Project Design

Clients can provide target molecular structures, functional requirements, or application directions (e.g., drug delivery, nanocarriers, or surface modification). The BOC Sciences scientific team will develop tailored conjugation strategies and synthetic routes based on the physicochemical properties, reactivity, and application goals of the lipids and polysaccharides, clarifying reaction mechanisms and expected performance.

Preliminary Verification & Small-Scale Experiments

Initial reactions are validated at small scale to assess lipid–polysaccharide binding efficiency, bond type, and feasibility of reaction conditions. By systematically optimizing solvents, temperature, reaction time, and catalyst ratios, we achieve high conjugation rates and structural stability, providing reliable data for subsequent scale-up.

Process Optimization & Scale-Up

Based on experimental validation, reaction kinetics and post-processing steps are further optimized to improve yield and product purity. Production can be flexibly scaled from milligrams to kilograms according to client needs, using GMP-grade equipment and clean environments to ensure process stability and reproducibility.

Purification & Quality Control

Unreacted components and by-products are efficiently removed using dialysis, gel filtration chromatography, ultrafiltration, or HPLC. Comprehensive verification of structure, molecular weight, degree of substitution, and lipid conjugation is conducted using NMR, FTIR, MS, GPC, and HPLC to ensure products meet design specifications.

Product Delivery & Documentation

Each project delivery includes a detailed technical report, structural identification data, purity analysis, and COA documents, allowing clients to fully understand product characteristics. Sample validation, performance testing, and stability assessment can be provided as needed to support subsequent research or industrial application.

Ongoing Technical Support & Collaborative Development

BOC Sciences offers continuous technical consultation and formulation optimization services, including adjustment of solubility, functional improvements, and expanded application scenarios for lipid–polysaccharide complexes. We encourage long-term research collaborations to help clients explore new conjugation strategies and innovative material development directions.

Major Applications of Lipid–Polysaccharide Conjugates

Lipid–polysaccharide conjugates combine the hydrophobicity of lipids with the hydrophilicity and biocompatibility of polysaccharides, forming multifunctional self-assembled systems widely used in drug delivery, biomaterials, diagnostics, food, and cosmetics.

Drug Delivery Systems

Lipid–polysaccharide conjugates can self-assemble into nanoparticles, micelles, or liposomes for delivering small molecules, proteins, peptides, and nucleic acid drugs. Their amphiphilic structures provide excellent membrane permeability and stability. By adjusting the lipid-to-polysaccharide ratio, controlled release, targeted delivery, and biodegradability can be achieved. These materials are widely applied in anticancer drugs, RNA therapeutics, and gene therapy.

Vaccines and Adjuvants

Lipid-modified polysaccharides enhance antigen delivery and immune stimulation. Conjugation with cholesterol, polyunsaturated fatty acids, or other lipids improves antigen stability and cellular uptake in vivo. Such systems are commonly used in mRNA vaccines, subunit vaccines, and peptide vaccines, helping to boost immunogenicity and enhance cellular immune responses.

Tissue Engineering & Biomaterials

Lipid–polysaccharide conjugates can serve as biodegradable scaffolds, hydrogels, or biomimetic membrane materials, offering excellent cell compatibility and tunable mechanical properties. Lipid incorporation improves hydrophobicity and structural stability, demonstrating superior performance in soft tissue repair, bone regeneration, wound healing, and neural scaffold construction.

Nanodiagnostics & Biosensing

Lipid–polysaccharide conjugates can function as stable nanoprobes or targeted sensing platforms for disease diagnostics, cell imaging, and bioassays. The polysaccharide component provides recognition and modification sites, while the lipid imparts membrane binding and self-assembly capabilities. Incorporation of fluorophores, magnetic elements, or electroactive molecules enables high-sensitivity biosensors for early cancer screening and in vivo imaging.

Frequently Asked Questions

Still have questions?

Contact Us

• What are the common conjugation reactions for lipid–polysaccharide conjugates?

  Typical reactions include esterification, amidation, click chemistry (e.g., CuAAC), and carbodiimide (EDC/NHS) activation. The choice depends on the functional groups of the lipid and polysaccharide, reaction mildness, and desired conjugation efficiency. Different reactions allow control over lipid substitution, conjugation sites, and molecular stability to meet drug delivery or material functionalization requirements.

• Can you support small-scale and large-scale production?

  We support scale-up from milligram-scale laboratory trials to kilogram-scale production. Small-scale trials optimize reaction conditions and yields, while large-scale production uses GMP-standard facilities to ensure batch consistency, product purity, and traceability, meeting R&D, preclinical, and industrial application needs.

• How are conjugate purity and structure verified?

  Conjugates are comprehensively analyzed using NMR, FTIR, HPLC, LC-MS, GPC, and other techniques to verify lipid–polysaccharide binding sites, degree of substitution, and molecular weight distribution. Analysis provides structural identification, purity assessment, and stability data for downstream applications.

• Can lipid–polysaccharide conjugates be used for drug delivery?

  Yes. They can self-assemble into nanoparticles, micelles, or liposomes for small molecules, proteins, or nucleic acids. Their amphiphilic structure improves membrane permeability and stability, enabling controlled release, targeting, or sustained delivery, widely applied in anticancer drugs, RNA therapeutics, and gene delivery platforms.

• Does BOC Sciences provide custom polysaccharide modification?

  We can pre-modify polysaccharides according to client needs, including oxidation, carboxylation, amination, or thiol group introduction, to improve subsequent lipid conjugation efficiency. Custom modifications allow precise control over conjugation sites and quantity while maintaining polysaccharide bioactivity, supporting functional applications.

Case Studies and Success Stories

Publications

Our publications section highlights real-world research achievements using BOC Sciences products or custom services.

• An advanced TALSPEAK concept for separating minor actinides. Part 2. Flowsheet test with actinide-spiked simulant. Solvent Extraction and Ion Exchange 35.6 (2017): 396-407. DOI: 10.1080/07366299.2017.1368945.
• Immune response and cytokine storm in SARS-CoV-2 infection: Risk factors, ways of control and treatment. European Journal of Inflammation 20 (2022): 1721727X221098970. DOI: 10.1177/1721727X221098970.
• Super-tough sustainable biobased composites from polylactide bioplastic and lignin for bio-elastomer application. Polymer 212 (2021): 123153. DOI: 10.1016/j.polymer.2020.123153.
• Cuban Policosanol (Raydel®) Exerts Higher Antioxidant and Anti-Glycation Activities than Chinese Policosanol (BOC Sciences) in Reconstituted High-Density Lipoproteins: In Vivo Anti-Inflammatory Activities in Zebrafish and Its Embryos. Pharmaceuticals 17.4 (2024): 406. DOI: 10.3390/ph17040406.
• Black cohosh extracts and powders induce micronuclei, a biomarker of genetic damage, in human cells. Environ Mol Mutagen. 2018; 59(5): 416-426. PMID: 29668046 DOI: 10.1002/em.22182.

Client Testimonials

Industry Distribution of Custom Lipid Synthesis Clients

"BOC Sciences supported our vaccine development by synthesizing a lipid–polysaccharide conjugate with excellent structural integrity. Their expertise in lipid chemistry and carbohydrate activation ensured consistent batch quality and timely delivery."

— Dr. Anna Peterson, Immunochemistry Scientist (United States)

"We needed a custom lipid–polysaccharide conjugate for adjuvant formulation research. BOC Sciences provided precise conjugation control and comprehensive analytical characterization, allowing us to move confidently into in vivo testing."

— Dr. Tomas Becker, Senior Research Scientist (Germany)

"Our team collaborated with BOC Sciences on developing glycolipid–polysaccharide constructs for targeted immune modulation. Their chemists demonstrated exceptional understanding of complex coupling reactions, achieving high conjugation efficiency and reproducibility."

— Ms. Julia Rossi, Vaccine Formulation Specialist (Italy)

"BOC Sciences delivered a high-quality lipid–polysaccharide conjugate that performed excellently in liposomal encapsulation studies. The project management was smooth, and their technical documentation met all regulatory standards."

— Dr. Robert Collins, CMC Development Manager (United Kingdom)

"We approached BOC Sciences to design a lipid–polysaccharide conjugate mimicking bacterial surface antigens. Their innovative approach and clear communication made the collaboration highly productive, with outstanding scientific outcomes."

— Dr. Eva Müller, Bioconjugation Scientist (Switzerland)

"BOC Sciences' lipid–polysaccharide conjugation service exceeded our expectations. The resulting amphiphilic conjugate showed remarkable stability and immunogenicity, providing a solid foundation for our vaccine formulation program."

— Dr. Mark Johnson, Biomedical Researcher (Canada)